Advertisement

Journal of Neurology

, Volume 255, Supplement 6, pp 82–86 | Cite as

Complementary and alternative medicine in multiple sclerosis

  • Annett Apel-Neu
  • U. K. Zettl
Article

Abstract

Complementary and alternative medicine (CAM) is often used by patients with multiple sclerosis (MS) but has been disregarded in research until lately. Various confounding factors on CAM utilisation exist, though have hardly been investigated. Besides socio-demographic variables like education, income, gender and age, illness-related factors like severity of disease are discussed. Furthermore, the important role of psychological factors on CAM utilisation is described. In particular, coping strategies such as “rumination”, “search for information” and “search for meaning in religion” are more often reported by CAM users than non-users and have important impact on CAM utilisation.

Key words

complementary and alternative medicine coping multiple sclerosis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Apel A, Greim B, König N, Zettl UK(2004) The role of coping and depressionin utilisation of complementaryand alternative medicine by multiplesclerosis patients. Mult Scler 10:S138–S139Google Scholar
  2. 2.
    Apel A, Greim B, König N, Zettl UK(2006) Frequency of current utilisationof complementary and alternativemedicine by patients with multiplesclerosis. J Neurol 253:1331–1336PubMedCrossRefGoogle Scholar
  3. 3.
    Apel A, Greim B, Zettl UK (2004)Utilisation of complementary andalternative medicine by multiplesclerosis patients. Mult Scler 10:S114–S115Google Scholar
  4. 4.
    Apel A, Greim B, Zettl UK (2007) Complementaryand alternative medicineand coping in neuroimmunologicaldiseases. J Neurol 254:II112–II115PubMedCrossRefGoogle Scholar
  5. 5.
    Astin JA (1998) Why patients use alternativemedicine. JAMA 279:1548–1553PubMedCrossRefGoogle Scholar
  6. 6.
    Bensoussan A (1999) Complementarymedicine – where lies its appeal? Med JAust 170:247–248Google Scholar
  7. 7.
    Berkman CS, Pignotti MG, Cavallo PF,Holland NJ (1999) Use of alternativetreatments by people with multiplesclerosis. Neurorehabil Neural Repair13:243–254CrossRefGoogle Scholar
  8. 8.
    Caspi O, Sechrest L, Pitluk HC,Marshall CL, Bell IR, Nichter M (2003)On the definition of complementary,alternative, and integrative medicine:societal mega-stereotypes vs. the patients’perspectives. Altern Ther HealthMed 9:58–62Google Scholar
  9. 9.
    Eisenberg DM, Davis RB, Ettner SL,Appel S, Wilkey S, Van Rompay M, et al.(1998) Trends in alternative medicineuse in the United States, 1990–1997:results of a follow-up national survey.JAMA 280:1569–1575PubMedCrossRefGoogle Scholar
  10. 10.
    Ernst E, Casseleth BR (1998) Theprevalence of complementary/alternativemedicine in cancer: a systematicreview. Cancer 83:777–782PubMedCrossRefGoogle Scholar
  11. 11.
    Feinstein A (1997) Multiple sclerosis,depression and suicide. BMJ 315:691–692PubMedGoogle Scholar
  12. 12.
    Furnham A, Kirkcaldy B (1996) Thehealth beliefs and behaviours of orthodoxand complementary medicineclients. Br J Clin Psychol 35:49–61PubMedGoogle Scholar
  13. 13.
    Kranz R, Rosenmund A (1998) Themotivation to use complementarymedicine healing methods. Study of ageneral internal medicine and orthopedicpatient sample. Schweiz MedWochenschr 128:616–622Google Scholar
  14. 14.
    Launso L (2000) Use of alternativetreatments in Denmark: patterns ofuse and patients’ experience withtreatment effects. Altern Ther HealthMed 6:102–107Google Scholar
  15. 15.
    Launso L, Haahr N (2007) Bridgebuilding and integrative treatment ofpeople with multiple sclerosis. Research-based evaluation of a team-buildingprocess. J Complement IntegrMed 4:article 7Google Scholar
  16. 16.
    MacLennan AH, Wilson DH, Taylor AW(1996) Prevalence and cost of alternativemedicine in Australia. Lancet 347:569–573PubMedCrossRefGoogle Scholar
  17. 17.
    Marrie RA, Hadjimichael O, Vollmer T(2003) Predictors of alternative medicineuse by multiple sclerosis patients.Mult Scler 9:461–466PubMedCrossRefGoogle Scholar
  18. 18.
    Melchart D, Mitscherlich F, Amiet M,Eichenberger R, Koch P (2005) ProgrammEvaluation Komplementärmedizin(PEK) Schlussbericht SwissFederal Office of Public HealthGoogle Scholar
  19. 19.
    Moschen R, Kemmler G, SchweigkoflerH, Holzner B, Dunser M, Richter R,et al. (2001) Use of alternative/complementarytherapy in breast cancerpatients – a psychological perspective.Support Care Cancer 9:267–274PubMedCrossRefGoogle Scholar
  20. 20.
    National Center of Complementaryand Alternative Medicine (NCCAM)(2008) What is complementary andalternative medicine (CAM)? http://nccam.nih.gov/health/whatiscam/Accessed: July 25, 2008Google Scholar
  21. 21.
    Nayak S, Matheis RJ, Schoenberger NE,Shiflett SC (2003) Use of unconventionaltherapies by individuals withmultiple sclerosis. Clin Rehabil 17:181–191PubMedCrossRefGoogle Scholar
  22. 22.
    Rajendran PR, Thompson RE, ReichSG (2001) The use of alternative therapiesby patients with Parkinson’s disease.Neurology 57:790–794PubMedGoogle Scholar
  23. 23.
    Sadovnik AD, Remick RA, Allen J,Swartz E, Yee IML, Eisen K (1996)Depression and multiple sclerosis.Neurology 46:628–632Google Scholar
  24. 24.
    Schubert DS, Foliart RH (1993) Increaseddepression in multiple sclerosispatients. A meta-analysis. Psychosomatics34:124–130PubMedGoogle Scholar
  25. 25.
    Schwartz CE, Laitin E, Brotman S,LaRocca N (1999) Utilization of unconventionaltreatments by personswith MS: is it alternative or complementary?Neurology 52:626–629PubMedGoogle Scholar
  26. 26.
    Sirois FM, Gick ML (2002) An investigationof health beliefs and motivationsof complementary medicineclients. Soc Sci Med 55:1025–1037PubMedCrossRefGoogle Scholar
  27. 27.
    Sirven JI, Drazkowski JF, ZimmermanRS, Bortz JJ, Shulman DL, Macleish M(2003) Complementary/alternativemedicine for epilepsy in Arizona.Neurology 61:576–577PubMedGoogle Scholar
  28. 28.
    Stenager E, Stenager EN, Knudsen L,Jensen K (1995) The use of non-medical/alternative treatment in multiplesclerosis. A 5 year follow-up study. ActaNeurol Belg 95:18–22Google Scholar
  29. 29.
    Stenager EN, Stenager E, Koch-HenriksenN, Bronnum-Hansen H, HyllestedK, Jensen K, et al. (1992) Suicide andmultiple sclerosis: an epidemiologicalinvestigation. J Neurol Neurosurg Psychiatry55:542–545PubMedCrossRefGoogle Scholar
  30. 30.
    Vincent C, Furnham A (1996) Why dopatients turn to complementary medicine?An empirical study. Br J Clin Psychol35:37–48PubMedGoogle Scholar
  31. 31.
    Vincent C, Furnham A (1997) Complementarymedicine: a research perspective.Wiley, ChichesterGoogle Scholar
  32. 32.
    Wang Y, Hashimoto S, Ramsum D,Findlay B, Best A, Oger J (1999) A pilotstudy of the use of alternative medicinein multiple sclerosis patients withspecial focus on acupuncture. Neurology52:A550Google Scholar
  33. 33.
    Wapf V, Busato A (2007) Patients’motives for choosing a physician:comparison between conventional andcomplementary medicine in Swissprimary care. BMC ComplementAltern Med 7:41CrossRefGoogle Scholar
  34. 34.
    Zollman C, Vickers A (1999) ABC ofcomplementary medicine. Complementarymedicine in conventionalpractice. BMJ 319:901–904PubMedGoogle Scholar

Copyright information

© Steinkopff-Verlag 2008

Authors and Affiliations

  1. 1.Dept. of NeurologyUniversity of RostockRostockGermany

Personalised recommendations